Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pulmonary Disease, Chronic Obstructive | 22 | 2020 | 3832 | 3.65 | Why? |
| Asthma | 11 | 2021 | 4383 | 1.53 | Why? |
| Nontuberculous Mycobacteria | 2 | 2018 | 114 | 1.35 | Why? |
| Mycobacterium Infections, Nontuberculous | 2 | 2018 | 167 | 1.21 | Why? |
| Electronic Health Records | 10 | 2021 | 3492 | 1.14 | Why? |
| Adrenergic beta-Antagonists | 2 | 2018 | 465 | 1.08 | Why? |
| Primary Health Care | 9 | 2021 | 4839 | 1.04 | Why? |
| Spirometry | 3 | 2018 | 524 | 0.81 | Why? |
| Bronchiectasis | 3 | 2018 | 312 | 0.78 | Why? |
| Trees | 1 | 2018 | 25 | 0.76 | Why? |
| Clinical Coding | 2 | 2018 | 172 | 0.76 | Why? |
| United Kingdom | 25 | 2021 | 18046 | 0.76 | Why? |
| Cost Savings | 1 | 2019 | 296 | 0.66 | Why? |
| Myocardial Reperfusion | 1 | 2017 | 168 | 0.62 | Why? |
| Nebulizers and Vaporizers | 1 | 2019 | 497 | 0.59 | Why? |
| General Practice | 3 | 2019 | 718 | 0.57 | Why? |
| Myocardial Infarction | 3 | 2018 | 3361 | 0.52 | Why? |
| Smoking | 5 | 2021 | 3358 | 0.49 | Why? |
| Diagnostic Errors | 1 | 2018 | 865 | 0.46 | Why? |
| Non-ST Elevated Myocardial Infarction | 1 | 2017 | 490 | 0.45 | Why? |
| Disease Management | 3 | 2019 | 6841 | 0.43 | Why? |
| Disease Progression | 10 | 2021 | 13580 | 0.42 | Why? |
| Respiratory Tract Diseases | 1 | 2019 | 1061 | 0.42 | Why? |
| Stroke | 3 | 2018 | 8839 | 0.41 | Why? |
| Respiratory Therapy | 1 | 2017 | 918 | 0.40 | Why? |
| Activities of Daily Living | 1 | 2018 | 1530 | 0.40 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.40 | Why? |
| Hypersensitivity | 2 | 2017 | 1137 | 0.40 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.39 | Why? |
| Patient Readmission | 1 | 2019 | 1543 | 0.39 | Why? |
| Heart Failure | 3 | 2019 | 6638 | 0.37 | Why? |
| Adrenal Cortex Hormones | 4 | 2021 | 6537 | 0.36 | Why? |
| Delayed Diagnosis | 1 | 2017 | 1529 | 0.33 | Why? |
| Lung | 5 | 2018 | 31049 | 0.32 | Why? |
| Referral and Consultation | 2 | 2019 | 4816 | 0.30 | Why? |
| Aged | 28 | 2021 | 215776 | 0.28 | Why? |
| Cardiovascular Diseases | 3 | 2021 | 11497 | 0.28 | Why? |
| Patient Selection | 2 | 2021 | 4560 | 0.28 | Why? |
| Databases, Factual | 5 | 2021 | 6248 | 0.26 | Why? |
| Respiration Disorders | 2 | 2021 | 526 | 0.26 | Why? |
| Lung Neoplasms | 2 | 2018 | 3228 | 0.25 | Why? |
| Brain Ischemia | 1 | 2018 | 2813 | 0.25 | Why? |
| Palliative Care | 1 | 2018 | 2665 | 0.25 | Why? |
| Middle Aged | 27 | 2021 | 270681 | 0.24 | Why? |
| Male | 31 | 2021 | 367725 | 0.24 | Why? |
| Follow-Up Studies | 5 | 2019 | 17020 | 0.24 | Why? |
| Female | 31 | 2021 | 380317 | 0.24 | Why? |
| Risk Assessment | 4 | 2019 | 25439 | 0.23 | Why? |
| Research Design | 3 | 2017 | 5830 | 0.23 | Why? |
| Risk Factors | 11 | 2021 | 71621 | 0.22 | Why? |
| Odds Ratio | 3 | 2017 | 5861 | 0.22 | Why? |
| Muscarinic Antagonists | 2 | 2020 | 176 | 0.22 | Why? |
| Patient Acceptance of Health Care | 4 | 2021 | 5002 | 0.22 | Why? |
| Prevalence | 7 | 2021 | 25773 | 0.21 | Why? |
| Quality of Life | 2 | 2019 | 9820 | 0.21 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2017 | 3051 | 0.21 | Why? |
| Commission on Professional and Hospital Activities | 1 | 2019 | 4 | 0.21 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.20 | Why? |
| Time-to-Treatment | 1 | 2017 | 5883 | 0.20 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.20 | Why? |
| Adrenergic beta-Agonists | 1 | 2019 | 93 | 0.19 | Why? |
| Respiratory Tract Infections | 2 | 2018 | 6817 | 0.19 | Why? |
| Humans | 45 | 2021 | 930598 | 0.19 | Why? |
| Cohort Studies | 7 | 2021 | 36005 | 0.19 | Why? |
| Case-Control Studies | 4 | 2018 | 17671 | 0.18 | Why? |
| Adiposity | 1 | 2021 | 329 | 0.18 | Why? |
| Reproducibility of Results | 4 | 2018 | 11304 | 0.17 | Why? |
| Secondary Care | 1 | 2018 | 160 | 0.17 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.17 | Why? |
| Health Status | 2 | 2021 | 3259 | 0.17 | Why? |
| Symptom Flare Up | 1 | 2021 | 432 | 0.17 | Why? |
| Academic Success | 1 | 2017 | 75 | 0.16 | Why? |
| Vital Capacity | 1 | 2018 | 399 | 0.16 | Why? |
| Severity of Illness Index | 8 | 2021 | 48226 | 0.16 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.16 | Why? |
| Quality of Health Care | 2 | 2019 | 1948 | 0.16 | Why? |
| Administration, Inhalation | 2 | 2020 | 1647 | 0.15 | Why? |
| Qualitative Research | 2 | 2018 | 4337 | 0.15 | Why? |
| Chronic Disease | 3 | 2021 | 5139 | 0.15 | Why? |
| Forced Expiratory Volume | 1 | 2018 | 632 | 0.15 | Why? |
| Adult | 17 | 2021 | 244371 | 0.14 | Why? |
| Survival Rate | 3 | 2019 | 9206 | 0.14 | Why? |
| Dyspnea | 2 | 2019 | 3847 | 0.14 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.14 | Why? |
| Costs and Cost Analysis | 1 | 2019 | 694 | 0.14 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.13 | Why? |
| Regression Analysis | 2 | 2020 | 2484 | 0.13 | Why? |
| Cause of Death | 2 | 2019 | 4823 | 0.13 | Why? |
| Comorbidity | 5 | 2020 | 34796 | 0.13 | Why? |
| England | 3 | 2021 | 5116 | 0.13 | Why? |
| Metabolic Syndrome | 1 | 2021 | 810 | 0.13 | Why? |
| Aged, 80 and over | 10 | 2021 | 88759 | 0.12 | Why? |
| Incidence | 4 | 2018 | 25622 | 0.12 | Why? |
| Anti-Asthmatic Agents | 1 | 2017 | 427 | 0.12 | Why? |
| State Medicine | 3 | 2021 | 2847 | 0.12 | Why? |
| Health Planning | 1 | 2019 | 607 | 0.12 | Why? |
| Logistic Models | 2 | 2017 | 9089 | 0.12 | Why? |
| Quality Indicators, Health Care | 1 | 2017 | 580 | 0.11 | Why? |
| Predictive Value of Tests | 2 | 2017 | 9537 | 0.11 | Why? |
| Prognosis | 4 | 2019 | 32490 | 0.11 | Why? |
| Body Mass Index | 3 | 2021 | 4306 | 0.11 | Why? |
| Adolescent | 9 | 2021 | 86841 | 0.10 | Why? |
| Aspirin | 1 | 2018 | 1043 | 0.10 | Why? |
| Medication Adherence | 1 | 2019 | 1270 | 0.10 | Why? |
| Lung Diseases, Interstitial | 1 | 2020 | 1476 | 0.10 | Why? |
| Drug Combinations | 1 | 2019 | 3852 | 0.10 | Why? |
| Risk | 2 | 2021 | 5288 | 0.10 | Why? |
| Smoking Cessation | 1 | 2017 | 826 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.09 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2018 | 1671 | 0.09 | Why? |
| Environmental Exposure | 1 | 2018 | 1558 | 0.09 | Why? |
| Treatment Outcome | 3 | 2019 | 51732 | 0.08 | Why? |
| Cost of Illness | 1 | 2018 | 1903 | 0.08 | Why? |
| Interrupted Time Series Analysis | 2 | 2021 | 868 | 0.08 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.08 | Why? |
| Terminal Care | 1 | 2017 | 928 | 0.08 | Why? |
| Clinical Protocols | 1 | 2018 | 2734 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.08 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.08 | Why? |
| Employment | 1 | 2017 | 1754 | 0.08 | Why? |
| Mobile Applications | 1 | 2021 | 3032 | 0.07 | Why? |
| Influenza Vaccines | 1 | 2021 | 2941 | 0.07 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.07 | Why? |
| Child, Preschool | 2 | 2019 | 36283 | 0.07 | Why? |
| Child | 5 | 2021 | 70012 | 0.07 | Why? |
| Retrospective Studies | 4 | 2020 | 105322 | 0.07 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.07 | Why? |
| Time Factors | 2 | 2017 | 31397 | 0.07 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.06 | Why? |
| Clinical Decision-Making | 1 | 2017 | 3755 | 0.06 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.06 | Why? |
| Surveys and Questionnaires | 3 | 2021 | 43792 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Community-Acquired Infections | 1 | 2013 | 2328 | 0.05 | Why? |
| Models, Statistical | 1 | 2018 | 5312 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.05 | Why? |
| Anti-Bacterial Agents | 2 | 2018 | 10083 | 0.05 | Why? |
| Mental Health | 2 | 2021 | 15770 | 0.04 | Why? |
| Mental Disorders | 1 | 2021 | 6742 | 0.04 | Why? |
| Validation Studies as Topic | 1 | 2017 | 121 | 0.04 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.04 | Why? |
| Multimorbidity | 1 | 2021 | 703 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Morbidity | 1 | 2021 | 1426 | 0.04 | Why? |
| Infant | 1 | 2017 | 30274 | 0.03 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.03 | Why? |
| Administration, Oral | 1 | 2021 | 2340 | 0.03 | Why? |
| Causality | 1 | 2017 | 857 | 0.03 | Why? |
| Pneumonia | 1 | 2013 | 5652 | 0.03 | Why? |
| Biological Specimen Banks | 1 | 2021 | 1142 | 0.03 | Why? |
| Intention | 1 | 2021 | 1380 | 0.03 | Why? |
| United States | 1 | 2019 | 46150 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Program Evaluation | 1 | 2019 | 1929 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.02 | Why? |
| Research | 1 | 2021 | 2115 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Geography | 1 | 2013 | 1801 | 0.02 | Why? |
| Consensus | 1 | 2021 | 6345 | 0.02 | Why? |
| Sex Distribution | 1 | 2013 | 2083 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Social Class | 1 | 2013 | 1360 | 0.02 | Why? |
| Drug Prescriptions | 1 | 2013 | 1062 | 0.02 | Why? |
| Japan | 1 | 2018 | 6653 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Age Distribution | 1 | 2013 | 3567 | 0.02 | Why? |
| Pneumonia, Viral | 2 | 2021 | 243684 | 0.01 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.01 | Why? |
| Internet | 1 | 2019 | 6204 | 0.01 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2021 | 6166 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2021 | 14232 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |